Cardioprotection in ischaemia-reperfusion injury: Novel mechanisms and clinical translation

Journal of Physiology

Volumn 593, Issue 17, 2015, Pages 3773-3788

  Altamirano, Francisco ^a   Wang, Zhao V ^a   Hill, Joseph A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARIPORIDE; ENIPORIDE; ENTINOSTAT; FIBRINOLYTIC AGENT; HEXOSAMINE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; OXYGEN; RANOLAZINE; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; STROMAL INTERACTION MOLECULE 1; TRANSCRIPTION FACTOR FKHRL1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TUBASTATIN A; UNCLASSIFIED DRUG; VORINOSTAT; CALCIUM;

CALCIUM TRANSPORT; CELL DEATH; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OCCLUSION; CORONARY STENTING; ENZYME INHIBITION; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MEDICAL RESEARCH; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; METABOLISM; MYOCARDIAL REPERFUSION INJURY;

ANIMALS; CALCIUM; HUMANS; MYOCARDIAL REPERFUSION INJURY;

EID: 84940567895     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270953     Document Type: Review

References (129)

1. Abarbanell AM, Herrmann JL, Weil BR, Wang Y, Tan J, Moberly SP, Fiege JW & Meldrum DR (2010). Animal models of myocardial and vascular injury. J Surg Res 162, 239-249.
2. 2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J Cell Mol Med 15, 2478-2485.
3. Ameri K & Harris AL (2008). Activating transcription factor 4. Int J Biochem Cell Biol 40, 14-21.
4. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG & Yancy CW (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61, e78-e140.
5. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW & Zieman SJ; ACC/AHA Task Force Members (2014). 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130, e344-e426.
6. Anderson S, Luffer-Atlas D & Knadler MP (2009). Predicting circulating human metabolites: how good are we? Chem Res Toxicol 22, 243-256.
7. Aune SE, Herr DJ, Mani SK & Menick DR (2014). Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. J Mol Cell Cardiol 72, 138-145.
8. Bernales S, McDonald KL & Walter P (2006). Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 4, e423.
9. Berridge MJ, Bootman MD & Roderick HL (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4, 517-529.
10. Bodi I, Mikala G, Koch SE, Akhter SA & Schwartz A (2005). The L-type calcium channel in the heart: the beat goes on. J Clin Invest 115, 3306-3317.
11. Brady NR, Hamacher-Brady A, Yuan H & Gottlieb RA (2007). The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic reticulum calcium stores. FEBS J 274, 3184-3197.
12. Brooks AC, Guo Y, Singh M, McCracken J, Xuan YT, Srivastava S, Bolli R & Bhatnagar A (2014). Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning. J Mol Cell Cardiol 76, 138-147.
13. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG & Ron D (2002). IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415, 92-96.
14. Champattanachai V, Marchase RB & Chatham JC (2007). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 292, C178-C187.
15. Champattanachai V, Marchase RB & Chatham JC (2008). Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294, C1509-C1520.
16. 2+ exchanger in cardiac ischemia/reperfusion injury. Med Sci Monit 18, RA161-RA165.
17. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV & Mann M (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
18. Collins HE, Zhu-Mauldin X, Marchase RB & Chatham JC (2013). STIM1/Orai1-mediated SOCE: current perspectives and potential roles in cardiac function and pathology. Am J Physiol Heart Circ Physiol 305, H446-H458.
19. Dassanayaka S & Jones SP (2014). O-GlcNAc and the cardiovascular system. Pharmacol Ther 142, 62-71.
20. Dixon JA & Spinale FG (2009). Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2, 262-271.
21. Dorn GW 2nd (2009). Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81, 465-473.
22. Doroudgar S, Thuerauf DJ, Marcinko MC, Belmont PJ & Glembotski CC (2009). Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response. J Biol Chem 284, 29735-29745.
23. Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM & Frankel SR (2007). Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 109, 31-39.
24. Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM & Bers DM (2013). Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502, 372-376.
25. Falkenberg KJ & Johnstone RW (2014). Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13, 673-691.
26. Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y, Reiken SR, Rauzier JM, Marchand A, Chauvier D, Cassan C, Crozier C, Bideaux P, Lompre AM, Jacotot E, Marks AR & Lacampagne A (2011). Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proc Natl Acad Sci USA 108, 13258-13263.
27. Fauconnier J, Roberge S, Saint N & Lacampagne A (2013). Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion. Pharmacol Ther 138, 323-332.
28. Földi I, Tóth AM, Szabó Z, Mózes E, Berkecz R, Datki ZL, Penke B & Janáky T (2013). Proteome-wide study of endoplasmic reticulum stress induced by thapsigargin in N2a neuroblastoma cells. Neurochem Int 62, 58-69.
29. Fulop N, Feng W, Xing D, He K, Not LG, Brocks CA, Marchase RB, Miller AP & Chatham JC (2008). Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology 9, 139-151.
30. Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A & Piper HM (2012). Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res 94, 168-180.
31. Garcia-Dorado D, Théroux P, Duran JM, Solares J, Alonso J, Sanz E, Munoz R, Elizaga J, Botas J, Fernandez-Avilés F, Soriano J & Esteban E (1992). Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 85, 1160-1174.
32. Ghelardoni S, Chiellini G, Frascarelli S & Zucchi R (2014). Cardioprotection by ranolazine in perfused rat heart. J Cardiovasc Pharmacol 64, 507-513.
33. Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas EI & Ferdinandy P (2014). Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 68, 75-78.
34. Glembotski CC (2014). Finding the missing link between the unfolded protein response and O-GlcNAcylation in the heart. Circ Res 115, 546-548.
35. Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA & Gruber PJ (2008). Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22, 3549-3560.
36. Gregoretti IV, Lee YM & Goodson HV (2004). Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 338, 17-31.
37. 2+-ATPase activity and inhibiting endoplasmic reticulum stress. J Cardiovasc Pharmacol 62, 143-153.
38. Halestrap AP (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38, 841-860.
39. Hamlin RL & Altschuld RA (2011). Extrapolation from mouse to man. Circ Cardiovasc Imaging 4, 2-4.
40. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M & Ron D (2000). Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6, 1099-1108.
41. Hart GW & Akimoto Y (2009). Essentials of Glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
42. Hart GW, Slawson C, Ramirez-Correa G & Lagerlof O (2011). Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80, 825-858.
43. Hausenloy DJ, Erik Bøtker H, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, Lecour S, vanLaake LW, Madonna R, Ruiz-Meana M, Schulz R, Sluijter JP, Yellon DM & Ovize M (2013). Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 98, 7-27.
44. Hausenloy DJ & Yellon DM (2013). Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123, 92-100.
45. Haze K, Yoshida H, Yanagi H, Yura T & Mori K (1999). Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10, 3787-3799.
46. Hetz C (2012). The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13, 89-102.
47. Hetz C, Chevet E & Harding HP (2013). Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12, 703-719.
48. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T & Schultz G (1999). Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397, 259-263.
49. 2+ channel α1 subunit (α1C-b) by the β2a subunit: a peptide which inhibits binding of β to the I-II linker of α1 induces functional uncoupling. Biochem J 348, 657-665.
50. Hoyer-Hansen M & Jaattela M (2007). Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ 14, 1576-1582.
51. Hu Y, Belke D, Suarez J, Swanson E, Clark R, Hoshijima M & Dillmann WH (2005). Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96, 1006-1013.
52. 2+ influx in stably transfected HEK293 cells. FEBS Lett 422, 333-338.
53. 2+ exchanger confers protection against ischemia/reperfusion injury. Circ Res 97, 916-921.
54. Jovanovic A, Alekseev AE, Lopez JR, Shen WK & Terzic A (1997). Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 63, 153-161.
55. 2+ loading: insight into cardioprotection during cardioplegia. Ann Thorac Surg 65, 586-591.
56. Kim SC, Boehm O, Meyer R, Hoeft A, Knüfermann P & Baumgarten G (2012). A murine closed-chest model of myocardial ischemia and reperfusion. J Vis Exp, e3896.
57. Kimball SR (1999). Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 31, 25-29.
58. Klocke R, Tian W, Kuhlmann MT & Nikol S (2007). Surgical animal models of heart failure related to coronary heart disease. Cardiovasc Res 74, 29-38.
59. 2+ paradox injury mediated through TRPC channels in mouse ventricular myocytes. Br J Pharmacol 161, 1734-1750.
60. Lara-Pezzi E, Menasché P, Trouvin JH, Badimón L, Ioannidis JP, Wu JC, Hill JA, Koch WJ, DeFelice AF, deWaele P, Steenwinckel V, Hajjar RJ & Zeiher AM (2015). Guidelines for translational research in heart failure. J Cardiovasc Transl Res 8, 3-22.
61. Levi AJ, Dalton GR, Hancox JC, Mitcheson JS, Issberner J, Bates JA, Evans SJ, Howarth FC, Hobai IA & Jones JV (1997). Role of intracellular sodium overload in the genesis of cardiac arrhythmias. J Cardiovasc Electrophysiol 8, 700-721.
62. Li Y, Zhu W, Tao J, Xin P, Liu M, Li J & Wei M (2012). Fasudil protects the heart against ischemia-reperfusion injury by attenuating endoplasmic reticulum stress and modulating SERCA activity: the differential role for PI3K/Akt and JAK2/STAT3 signaling pathways. PLoS One 7, e48115.
63. Lin JH & Lu AY (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49, 403-449.
64. Lin S, Lin Y, Nery JR, Urich MA, Breschi A, Davis CA, Dobin A, Zaleski C, Beer MA, Chapman WC, Gingeras TR, Ecker JR & Snyder MP (2014). Comparison of the transcriptional landscapes between human and mouse tissues. Proc Natl Acad Sci U S A 111, 17224-17229.
65. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC & Marchase RB (2006). Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40, 303-312.
66. 2+ waves: a laser confocal microscopy study. Am J Physiol 270, H1384-H1389.
67. Ludman AJ, Yellon DM & Hausenloy DJ (2010). Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 3, 35-38.
68. 2+ entry is required for pathological cardiac hypertrophy. J Mol Cell Cardiol 52, 136-147.
69. Makarewich CA, Zhang H, Davis J, Correll RN, Trappanese DM, Hoffman NE, Troupes CD, Berretta RM, Kubo H, Madesh M, Chen X, Gao E, Molkentin JD & Houser SR (2014). Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ Res 115, 567-580.
70. Marsh SA, Collins HE & Chatham JC (2014). Protein O-GlcNAcylation and cardiovascular (patho)physiology. J Biol Chem 289, 34449-34456.
71. Martindale JJ, Fernandez R, Thuerauf D, Whittaker R, Gude N, Sussman MA & Glembotski CC (2006). Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 98, 1186-1193.
72. Mathers CD & Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3, e442.
73. Matsushima S, Tsutsui H & Sadoshima J (2014). Physiological and pathological functions of NADPH oxidases during myocardial ischemia-reperfusion. Trends Cardiovasc Med 24, 202-205.
74. Miyazaki Y, Kaikita K, Endo M, Horio E, Miura M, Tsujita K, Hokimoto S, Yamamuro M, Iwawaki T, Gotoh T, Ogawa H & Oike Y (2011). C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation. Arterioscler Thromb Vasc Biol 31, 1124-1132.
75. Mori K (2009). Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146, 743-750.
76. Murphy E & Steenbergen C (2008). Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88, 581-609.
77. Muth JN, Bodi I, Lewis W, Varadi G & Schwartz A (2001). A Ca2+-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Cα. Circulation 103, 140-147.
78. Nabel EG & Braunwald E (2012). A tale of coronary artery disease and myocardial infarction. N Engl J Med 366, 54-63.
79. Ngoh GA, Watson LJ, Facundo HT & Jones SP (2011). Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 40, 895-911.
80. Nishimura T, Hu Y, Wu M, Pham E, Suemizu H, Elazar M, Liu M, Idilman R, Yurdaydin C, Angus P, Stedman C, Murphy B, Glenn J, Nakamura M, Nomura T, Chen Y, Zheng M, Fitch WL & Peltz G (2013). Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction. J Pharmacol Exp Ther 344, 388-396.
81. O'Donnell JM, Pound K, Xu X & Lewandowski ED (2009). SERCA1 expression enhances the metabolic efficiency of improved contractility in post-ischemic heart. J Mol Cell Cardiol 47, 614-621.
82. Oerlemans MI, Koudstaal S, Chamuleau SA, deKleijn DP, Doevendans PA & Sluijter JP (2013). Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 165, 410-422.
83. Okada H, Lai NC, Kawaraguchi Y, Liao P, Copps J, Sugano Y, Okada-Maeda S, Banerjee I, Schilling JM, Gingras AR, Asfaw EK, Suarez J, Kang SM, Perkins GA, Au CG, Israeli-Rosenberg S, Manso AM, Liu Z, Milner DJ, Kaufman SJ, Patel HH, Roth DM, Hammond HK, Taylor SS, Dillmann WH, Goldhaber JI & Ross RS (2013). Integrins protect cardiomyocytes from ischemia/reperfusion injury. J Clin Invest 123, 4294-4308.
84. 2+ depletion during the unfolded protein response in Xenopus oocytes: cause and consequence. Cell Calcium 53, 286-296.
85. Patten RD & Hall-Porter MR (2009). Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2, 138-144.
86. Perricone AJ & Vander Heide RS (2014). Novel therapeutic strategies for ischemic heart disease. Pharmacol Res 89C, 36-45.
87. Ruiz-Meana M, Abellán A, Miró-Casas E, Agulló E & Garcia-Dorado D (2009). Role of sarcoplasmic reticulum in mitochondrial permeability transition and cardiomyocyte death during reperfusion. Am J Physiol Heart Circ Physiol 297, H1281-H1289.
88. Sawada T, Minamino T, Fu HY, Asai M, Okuda K, Isomura T, Yamazaki S, Asano Y, Okada K, Tsukamoto O, Sanada S, Asanuma H, Asakura M, Takashima S, Kitakaze M & Komuro I (2010). X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes. J Mol Cell Cardiol 48, 1280-1289.
89. 2+ leakage from the ER. EMBO J 31, 3282-3296.
90. Schindler AJ & Schekman R (2009). In vitro reconstitution of ER-stress induced ATF6 transport in COPII vesicles. Proc Natl Acad Sci U S A 106, 17775-17780.
91. Shan D, Marchase RB & Chatham JC (2008). Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes. Am J Physiol Cell Physiol 294, C833-C841.
92. Sluijter JP, Condorelli G, Davidson SM, Engel FB, Ferdinandy P, Hausenloy DJ, Lecour S, Madonna R, Ovize M, Ruiz-Meana M, Schulz R & VanLaake LW; Nucleus of the European Society of Cardiology Working Group Cellular Biology of the Heart (2014). Novel therapeutic strategies for cardioprotection. Pharmacol Ther 144, 60-70.
93. Szegezdi E, Duffy A, O'Mahoney ME, Logue SE, Mylotte LA, O'Brien T & Samali A (2006). ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem Biophys Res Commun 349, 1406-1411.
94. 2+ handling and decreases myocardial infarction. Am J Physiol Heart Circ Physiol 293, H2418-H2428.
95. Talukder MA, Zweier JL & Periasamy M (2009). Targeting calcium transport in ischaemic heart disease. Cardiovasc Res 84, 345-352.
96. Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I & Hirota H (2005). AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25, 9554-9575.
97. Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT & Jessel A (2000). Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation 102, 3032-3038.
98. Thompson-Gorman SL & Zweier JL (1990). Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J Biol Chem 265, 6656-6663.
99. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA & Glembotski CC (2006). Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res 99, 275-282.
100. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ & Mendis S (2012). Third universal definition of myocardial infarction. Circulation 126, 2020-2035.
101. Turer AT & Hill JA (2010). Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol 106, 360-368.
102. 2+ depletion of the sarcoplasmic reticulum at the onset of reperfusion. Cardiovasc Res 85, 671-680.
103. Vander Heide RS & Steenbergen C (2013). Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res 113, 464-477.
104. Viola HM, Jordan MC, Roos KP & Hool LC (2014). Decreased myocardial injury and improved contractility after administration of a peptide derived against the alpha-interacting domain of the L-type calcium channel. J Am Heart Assoc 3, e000961.
105. Walter P & Ron D (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086.
106. Wang ZV, Deng Y, Gao N, Pedrozo Z, Li DL, Morales CR, Criollo A, Luo X, Tan W, Jiang N, Lehrman MA, Rothermel BA, Lee AH, Lavandero S, Mammen PP, Ferdous A, Gillette TG, Scherer PE & Hill JA (2014). Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Cell 156, 1179-1192.
107. 2+-ATPase in sarcoplasmic reticulum after reperfusion. Eur J Cardiothorac Surg 22, 951-956.
108. Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, Lemma KM, Long BW, Prabhu SD, Xuan YT & Jones SP (2010). O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A 107, 17797-17802.
109. Wessels A & Sedmera D (2003). Developmental anatomy of the heart: a tale of mice and man. Physiol Genomics 15, 165-176.
110. West AC & Johnstone RW (2014). New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124, 30-39.
111. Wimmer NJ & Stone PH (2013). Anti-anginal and anti-ischemic effects of late sodium current inhibition. Cardiovasc Drugs Ther 27, 69-77.
112. Wu X, Eder P, Chang B & Molkentin JD (2010). TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci U S A 107, 7000-7005.
113. Xie M & Hill JA (2013). HDAC-dependent ventricular remodeling. Trends Cardiovasc Med 23, 229-235.
114. Xie M, Kong Y, Tan W, May H, Battiprolu PK, Pedrozo Z, Wang ZV, Morales C, Luo X, Cho G, Jiang N, Jessen ME, Warner JJ, Lavandero S, Gillette TG, Turer AT & Hill JA (2014). Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129, 1139-1151.
115. Xu Z, Alloush J, Beck E & Weisleder N (2014). A murine model of myocardial ischemia-reperfusion injury through ligation of the left anterior descending artery. J Vis Exp; doi: 10.3791/51329.
116. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, Harada A & Mori K (2007). Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6α and XBP1. Dev Cell 13, 365-376.
117. Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS & Goldstein JL (2000). ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6, 1355-1364.
118. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV & Go AS (2010). Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362, 2155-2165.
119. Yellon DM & Hausenloy DJ (2007). Myocardial reperfusion injury. N Engl J Med 357, 1121-1135.
120. Yokoe S, Asahi M, Takeda T, Otsu K, Taniguchi N, Miyoshi E & Suzuki K (2010). Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Glycobiology 20, 1217-1226.
121. Yoshida H, Matsui T, Yamamoto A, Okada T & Mori K (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.
122. Young ME, Yan J, Razeghi P, Cooksey RC, Guthrie PH, Stepkowski SM, McClain DA, Tian R & Taegtmeyer H (2007). Proposed regulation of gene expression by glucose in rodent heart. Gene Regul Syst Bio 1, 251-262.
123. Zachara NE (2012). The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease. Am J Physiol Heart Circ Physiol 302, H1905-H1918.
124. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38, 1644-1650.
125. 2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated μ-calpain cleavage. Biochemistry 45, 11681-11694.
126. Zhao TC, Cheng G, Zhang LX, Tseng YT & Padbury JF (2007). Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76, 473-481.
127. Zhu-Mauldin X, Marsh SA, Zou L, Marchase RB & Chatham JC (2012). Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes. J Biol Chem 287, 39094-39106.
128. Zou L, Zhu-Mauldin X, Marchase RB, Paterson AJ, Liu J, Yang Q & Chatham JC (2012). Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent. J Biol Chem 287, 34419-34431.
129. Zucchi R, Ronca F & Ronca-Testoni S (2001). Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther 89, 47-65.